Form 4: Biohaven Director John W. Childs Increases Stake in Company Through Charitable Trusts

Director John W. Childs reports acquiring additional Biohaven shares through various charitable remainder trusts and a revocable trust.

Summary

• On April 22, 2024, John W. Childs, a director of Biohaven Ltd., acquired additional common shares of the company.
• The purchases were made through several trusts, including the 1994 Charitable Remainder Trust, the 2021 B-H Charitable Remainder Trust, and the John W. Childs 2013 Revocable Trust.
• A total of 24,391 shares were acquired by the 1994 Charitable Remainder Trust, 97,560 shares by the 2021 B-H Charitable Remainder Trust, and 73,170 shares by the John W. Childs 2013 Revocable Trust.
• All shares were purchased at a price of $41 per share as part of an underwritten public offering.
• Following these transactions, the 1994 Charitable Remainder Trust holds 24,391 shares, the 2021 B-H Charitable Remainder Trust holds 4,096,512 shares, and the John W. Childs 2013 Revocable Trust holds 2,254,841 shares.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as a director is increasing their stake in the company, which is generally viewed favorably by investors.

Positives

• A director's increased investment in the company may signal confidence in Biohaven's future prospects.

Industry Context

Directors purchasing shares can be seen as a positive signal, aligning their interests with those of other shareholders. It's common for insiders to make such purchases, especially during public offerings.

Stakeholder Impact

• Shareholders may view the director's increased investment positively.

Key Dates